Ledger.Open graph →

SEC Form D · filed August 2, 2023

K2 Biolabs, Inc

Offering

$3.0M

Sold

$616K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Houston, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Clifford J. Stocks · Houston, TXDirector Kevin Slawin · HOUSTON, TXDirector Andrew Desomma · Tesuque, NMDirector Gerard Fleury · Houston, TXDirector Andrew J. Strong · Houston, TXDirector Daniel J. Clark · Houston, TXExec Kieron Jones · HOUSTON, TXExec · Director Andrew Desomma · Tesuque, NMDirector Gerard Fleury · Houston, TXDirector Clifford J. Stocks · Houston, TXDirector Andrew J. Strong · Houston, TXDirector Daniel J. Clark · Houston, TXExec Kevin Slawin · HOUSTON, TXDirector Kieron Jones · HOUSTON, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗